StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research note published on Saturday. The brokerage issued a hold rating on the stock.

China Pharma Trading Down 7.4 %

NYSE CPHI opened at $0.19 on Friday. The business’s fifty day simple moving average is $0.20 and its 200-day simple moving average is $0.22. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a 52 week low of $0.13 and a 52 week high of $0.60.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.